EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fecal short‐chain fatty acids vary by sex and amyloid status

Jessamine F Kuehn iD, Qijun Zhang, Margo B Heston, Jea Woo Kang, Sandra J Harding, Nancy J Davenport-Sis, Darby C Peter, Robert L Kerby, Vaibhav Vemuganti, Emma C Schiffmann, Michael M Tallon, Joseph Harpt und 22 weitere

Alzheimer's & Dementia · 2025-11 · 21 (11)

DOI: 10.1002/alz.70877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 22.11.2025. Verfasst von Jessamine F Kuehn und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Feces, Gastrointestinal Microbiome, Alzheimer Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Alzheimer's Foundation, National Science Foundation Graduate Research Fellowship Program, the Alzheimer's Association 2022-2025 Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Short‐chain fatty acids (SCFAs), produced by gut microbes, influence Alzheimer's disease (AD) pathology in animals. Less is known about SCFAs and AD in humans. We profiled feces of adults along the AD continuum to investigate gut microbiome and SCFA associations with AD pathology and cognition. METHODS We measured SCFAs and bacterial abundances in fecal samples from 287 participants in the Wisconsin Alzheimer's Disease Research Center and Wisconsin Registry for Alzheimer's Prevention. We performed regressions examining associations between SCFAs or gut microbes and AD pathology and cognition. RESULTS Fecal propionate, isovalerate, and propionate‐producing bacteria are inversely associated with amyloid status. Mediation analysis found that propionate mediates sex‐specific associations between SCFAs and cerebrospinal fluid biomarkers. SCFA levels are associated with slower cognitive decline. DISCUSSION These results link SCFAs and propionate‐producing bacteria with AD. This may inform efforts to leverage diet and specific bacteria to boost SCFA production and potentially ameliorate AD progression. Highlights Fecal SCFAs link to lower amyloid burden and microglial activation, notably in females. SCFA‐producing gut microbes have reduced abundance in amyloid‐positive participants. Fecal propionate mediates relationships between gut microbes and amyloid status. SCFAs are associated with slower plasma pTau 217 accumulation in females. SCFAs are associated with slower cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, VolatileFecesGastrointestinal MicrobiomeAlzheimer DiseaseHumansFemaleMaleAgedSex FactorsBiomarkersCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer's diseaseamyloidbacteriacerebrospinal fluid biomarkersgut microbiomemetabolitesmicrobiotashort‐chain fatty acids

Substanzen

Fatty Acids, VolatileBiomarkers

Autor:innen und Institutionen

  • Department of Bacteriology, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Molecular and Cellular Pharmacology Graduate Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Roche Diagnostics GmbH, Penzberg, Germany.
  • Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
  • Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.

ORCID-Profile: Jessamine F Kuehn

Förderung

  • Swedish Alzheimer's Foundation
  • National Science Foundation Graduate Research Fellowship Program
  • the Alzheimer's Association 2022-2025 Grant
  • the Graduate School and the Office of the Vice Chancellor for Research, University of Wisconsin-Madison
  • NIA NIH HHS
  • Swedish State Support for Clinical Research
  • an anonymous philanthropist and donor
  • NINDS NIH HHS

Zitieren

APA

Kuehn, J. F., Zhang, Q., Heston, M. B., Kang, J. W., Harding, S. J., Davenport-Sis, N. J., Peter, D. C., Kerby, R. L., Vemuganti, V., Schiffmann, E. C., Tallon, M. M., Harpt, J., Hajra, A., Wheeler, J. L., Shankar, S., Mickol, A., Zemberi, J., Chow, H., Zhang, E., …, & Bendlin, B. B. (2025). Fecal short‐chain fatty acids vary by sex and amyloid status. Alzheimer's & Dementia, 21(11). https://doi.org/10.1002/alz.70877

Vancouver

Kuehn JF, Zhang Q, Heston MB, Kang JW, Harding SJ, Davenport-Sis NJ, et al. Fecal short‐chain fatty acids vary by sex and amyloid status. Alzheimer's & Dementia. 2025;21(11). doi:10.1002/alz.70877

BibTeX
@article{Kuehn2025,
  author = {Kuehn, Jessamine F and Zhang, Qijun and Heston, Margo B and Kang, Jea Woo and Harding, Sandra J and Davenport-Sis, Nancy J and Peter, Darby C and Kerby, Robert L and Vemuganti, Vaibhav and Schiffmann, Emma C and Tallon, Michael M and Harpt, Joseph and Hajra, Arun and Wheeler, J L and Shankar, Sushma and Mickol, Alissa and Zemberi, Justus and Chow, Hana and Zhang, Eric and Clements, Eleanor and Noughani, Hanna and Forst, Allison and Everitt, Grace and Kollmorgen, Gwendlyn and Quijano-Rubio, Clara and Christian, Bradley T and Carlsson, Cynthia M and Johnson, Sterling C and Asthana, Sanjay and Zetterberg, Henrik and Blennow, Kaj and Ulland, Tyler K and Rey, Federico E and Bendlin, Barbara B},
  title = {Fecal short‐chain fatty acids vary by sex and amyloid status},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {11},
  doi = {10.1002/alz.70877}
}
Kostenlos starten →